title: Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.
abstract: Work in our laboratory has focused on the mechanisms by which cytokines can influence the brain and behavior in humans and non-human primates. Using administration of interferon (IFN)-alpha as a tool to unravel these mechanisms, we have expanded upon findings from the basic science literature implicating cytokine-induced changes in monoamine metabolism as a primary pathway to depression. More specifically, a role for serotonin metabolism has been supported by the clinical efficacy of serotonin reuptake inhibitors in blocking the development of IFN-alpha-induced depression, and the capacity of IFN-alpha to activate metabolic enzymes (indolamine 2,3 dioxygenase) and cytokine signaling pathways (p38 mitogen activated protein kinase) that can influence the synthesis and reuptake of serotonin. Our data also support a role for dopamine depletion as reflected by IFN-alpha-induced changes in behavior (psychomotor slowing and fatigue) and regional brain activity, which implicate the involvement of the basal ganglia, as well as the association of IFN-alpha-induced depressive-like behavior in rhesus monkeys with decreased cerebrospinal fluid concentrations of the dopamine metabolite, homovanillic acid. Neuroimaging data in IFN-alpha-treated patients also suggest that activation of neural circuits (dorsal anterior cingulate cortex) associated with anxiety and alarm may contribute to cytokine-induced behavioral changes. Taken together, these effects of cytokines on the brain and behavior appear to subserve competing evolutionary survival priorities that promote reduced activity to allow healing, and hypervigilance to protect against future attack. Depending on the relative balance between these behavioral accoutrements of an activated innate immune response, clinical presentations may be distinct and warrant individualized therapeutic approaches.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Winship Cancer Institute, Emory University School of Medicine, 1701 Uppergate Drive, WCI Building C, 5th Floor, Atlanta, GA 30322, USA. amill02@emory.edu
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Miller
mesh_terms: D000818:Animals; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology; D001519:Behavior / Q000187:drug effects; D016207:Cytokines / Q000276:immunology; D003863:Depression / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology*; D004298:Dopamine / Q000134:cerebrospinal fluid; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism; D016898:Interferon-alpha / Q000008:administration & dosage / Q000276:immunology*; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D016207:Cytokines; D004298:Dopamine; D006719:Homovanillic Acid; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D016898:Interferon-alpha; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: Atherosclerosis. 2007 Dec;195(2):e10-8
references.pmid: 17669411
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1920-5
references.pmid: 12578963
references.citation: Biol Psychiatry. 2006 May 1;59(9):775-85
references.pmid: 16458261
references.citation: Mol Psychiatry. 2010 May;15(5):535-47
references.pmid: 18521089
references.citation: N Engl J Med. 1999 Apr 29;340(17):1370
references.pmid: 10223879
references.citation: Brain Behav Immun. 2007 May;21(4):374-83
references.pmid: 17360153
references.citation: Arch Gen Psychiatry. 2008 Apr;65(4):409-15
references.pmid: 18391129
references.citation: Biol Psychiatry. 2003 Nov 1;54(9):906-14
references.pmid: 14573318
references.citation: Neuroreport. 2001 Dec 21;12(18):4121-5
references.pmid: 11742250
references.citation: J Immunother. 2007 Apr;30(3):333-7
references.pmid: 17414324
references.citation: Arch Gen Psychiatry. 2005 Nov;62(11):1228-36
references.pmid: 16275810
references.citation: Mol Psychiatry. 2007 Oct;12(10):895-7
references.pmid: 17895923
references.citation: Am J Psychiatry. 2006 Sep;163(9):1630-3
references.pmid: 16946190
references.citation: Am J Psychiatry. 2001 Feb;158(2):314-6
references.pmid: 11156819
references.citation: Mol Psychiatry. 2001 Jul;6(4):475-80
references.pmid: 11443537
references.citation: Comput Med Imaging Graph. 1995 May-Jun;19(3):295-306
references.pmid: 7641174
references.citation: Neurology. 2004 Oct 26;63(8 Suppl 3):S2-7
references.pmid: 15505137
references.citation: Gen Hosp Psychiatry. 1999 Mar-Apr;21(2):134-5
references.pmid: 10228895
references.citation: Circulation. 2003 Jan 28;107(3):363-9
references.pmid: 12551853
references.citation: Brain Behav Immun. 2008 Aug;22(6):870-80
references.pmid: 18258414
references.citation: Neurology. 2001 Dec 11;57(11):2083-8
references.pmid: 11739830
references.citation: N Engl J Med. 2001 Mar 29;344(13):961-6
references.pmid: 11274622
references.citation: J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):185-91
references.pmid: 15939972
references.citation: Neuropathol Appl Neurobiol. 2005 Aug;31(4):395-404
references.pmid: 16008823
references.citation: Biol Psychiatry. 2002 Oct 1;52(7):740-8
references.pmid: 12372665
references.citation: J Neuroimmunol. 2007 Feb;183(1-2):125-32
references.pmid: 17229471
references.citation: Neuroimmunomodulation. 1995 Jul-Aug;2(4):216-23
references.pmid: 8963750
references.citation: J Clin Psychiatry. 2005 Jan;66(1):41-8
references.pmid: 15669887
references.citation: J Neurosci. 2003 Sep 17;23(24):8480-8
references.pmid: 13679416
references.citation: J Neurochem. 2004 Oct;91(1):220-9
references.pmid: 15379902
references.citation: Neuroscience. 1991;41(1):1-24
references.pmid: 1676137
references.citation: Eur Neuropsychopharmacol. 2000 Mar;10(2):129-32
references.pmid: 10706995
references.citation: Neuropsychopharmacology. 2008 Jun;33(7):1503-13
references.pmid: 17882235
references.citation: J Neural Transm Gen Sect. 1993;91(2-3):75-109
references.pmid: 8099801
references.citation: Science. 2003 Jul 18;301(5631):386-9
references.pmid: 12869766
references.citation: Arch Gen Psychiatry. 1992 Jun;49(6):447-50
references.pmid: 1376107
references.citation: Brain Res. 1996 Mar 4;711(1-2):163-74
references.pmid: 8680860
references.citation: Biol Psychiatry. 1994 Jan 15;35(2):128-32
references.pmid: 8167208
references.citation: J Neurol Sci. 2000 Oct 1;179(S 1-2):34-42
references.pmid: 11054483
references.citation: Ann Neurol. 1990 Jul;28(1):57-64
references.pmid: 2375634
references.citation: Psychol Sci. 2003 Jul;14(4):347-53
references.pmid: 12807408
references.citation: Cogn Affect Behav Neurosci. 2005 Jun;5(2):169-81
references.pmid: 16180623
references.citation: CNS Drugs. 2005;19(2):105-23
references.pmid: 15697325
references.citation: J Clin Psychiatry. 2005 Aug;66(8):1050-7
references.pmid: 16086622
references.citation: Annu Rev Neurosci. 2007;30:259-88
references.pmid: 17600522
references.citation: Arch Gen Psychiatry. 2007 Mar;64(3):327-37
references.pmid: 17339521
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):11-38
references.pmid: 7708925
references.citation: J Neurosci. 1995 Jan;15(1 Pt 1):376-84
references.pmid: 7823142
references.citation: Trends Cogn Sci. 2004 Jul;8(7):294-300
references.pmid: 15242688
references.citation: Science. 1998 May 1;280(5364):747-9
references.pmid: 9563953
references.citation: Pharmacol Biochem Behav. 1992 May;42(1):57-60
references.pmid: 1528947
references.citation: Vet Clin North Am Small Anim Pract. 1991 Mar;21(2):225-37
references.pmid: 2053246
references.citation: Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S203-6
references.pmid: 14677080
references.citation: Brain Behav Immun. 2007 Feb;21(2):153-60
references.pmid: 17088043
references.citation: Science. 1972 Mar 24;175(4028):1380-2
references.pmid: 5059569
references.citation: Adv Neurol. 2003;91:9-18
references.pmid: 12442660
references.citation: Psychosom Med. 2001 May-Jun;63(3):376-86
references.pmid: 11382265
references.citation: Clin Neuropathol. 2001 Jul-Aug;20(4):146-55
references.pmid: 11495003
references.citation: Nature. 1999 Aug 12;400(6745):621-2
references.pmid: 10458157
references.citation: Brain Res. 2003 Jul 18;978(1-2):104-14
references.pmid: 12834904
references.citation: Fed Proc. 1985 Jan;44(1 Pt 2):249-53
references.pmid: 3871411
references.citation: Biol Psychiatry. 2005 Aug 1;58(3):190-6
references.pmid: 16084839
references.citation: Psychol Med. 1997 Nov;27(6):1247-56
references.pmid: 9403896
references.citation: J Neurovirol. 1999 Oct;5(5):500-6
references.pmid: 10568887
references.citation: Lancet. 2006 Jan 7;367(9504):29-35
references.pmid: 16399150
references.citation: Dis Nerv Syst. 1971 Nov;32(11):735-41
references.pmid: 5002259
references.citation: Trends Immunol. 2006 Jan;27(1):24-31
references.pmid: 16316783
references.citation: Mov Disord. 2001 Mar;16(2):190-6
references.pmid: 11295769
references.citation: J Pharmacol Exp Ther. 1988 Mar;244(3):1067-80
references.pmid: 2855239
references.citation: Neurosci Biobehav Rev. 1992 Winter;16(4):525-34
references.pmid: 1480349
references.citation: J Neural Transm (Vienna). 2007 Jan;114(1):33-41
references.pmid: 16932989
references.citation: Neuropsychopharmacology. 2006 Oct;31(10):2121-31
references.pmid: 16452991
references.citation: World J Biol Psychiatry. 2007;8(3):141-74
references.pmid: 17654407
references.citation: Brain Behav Immun. 1997 Jun;11(2):107-18
references.pmid: 9299060
references.citation: Arch Gen Psychiatry. 2001 May;58(5):445-52
references.pmid: 11343523
references.citation: Neurosci Lett. 2006 Apr 24;397(3):254-8
references.pmid: 16406668
references.citation: J Clin Psychiatry. 2006;67 Suppl 6:3-8
references.pmid: 16848670
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1605-21
references.pmid: 16889756
references.citation: Mol Psychiatry. 2002;7(5):468-73
references.pmid: 12082564
references.citation: Nat Rev Neurosci. 2008 Jan;9(1):46-56
references.pmid: 18073775
references.citation: Mov Disord. 2003 Oct;18(10):1108-14
references.pmid: 14534913
references.citation: Biol Psychiatry. 2004 Jun 15;55(12):1179-87
references.pmid: 15184037
references.citation: J Pharmacol Exp Ther. 2003 Apr;305(1):1-8
references.pmid: 12649346
references.citation: J Cereb Blood Flow Metab. 1994 Sep;14(5):783-801
references.pmid: 8063874
references.citation: Life Sci. 2000 Jun 30;67(6):663-9
references.pmid: 12659172
references.citation: Aliment Pharmacol Ther. 2007 May 15;25(10):1163-74
references.pmid: 17451562
references.citation: Biol Psychiatry. 1992 Jan 15;31(2):112-8
references.pmid: 1371076
references.citation: J Biol Chem. 2005 Apr 22;280(16):15649-58
references.pmid: 15728187
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1319-24
references.pmid: 17229839
references.citation: Clin Neuropharmacol. 2000 Jan-Feb;23(1):59-61
references.pmid: 10682234
references.citation: Curr Opin Pharmacol. 2005 Feb;5(1):34-41
references.pmid: 15661623
references.citation: Oncol Nurs Forum. 2002 Aug;29(7):E85-90
references.pmid: 12183762
references.citation: Psychol Rev. 1998 Jan;105(1):83-107
references.pmid: 9450372
references.citation: Am J Psychiatry. 2002 May;159(5):746-54
references.pmid: 11986127
references.citation: Biol Psychiatry. 2004 Dec 1;56(11):819-24
references.pmid: 15576057
references.citation: Ann N Y Acad Sci. 2003 Jun;991:199-213
references.pmid: 12846988
references.citation: Am J Psychiatry. 2003 Jul;160(7):1342-5
references.pmid: 12832253
references.citation: Psychosomatics. 2000 Sep-Oct;41(5):439-41
references.pmid: 11015632
references.citation: Mol Psychiatry. 2005 Jun;10(6):538-44
references.pmid: 15494706
references.citation: J Biol Chem. 2007 Mar 16;282(11):7783-9
references.pmid: 17227768
references.citation: J Neuroinflammation. 2005 Jul 26;2:16
references.pmid: 16042813
references.citation: Neurosci Lett. 2005 Feb 28;375(2):107-11
references.pmid: 15670651
references.citation: J Neurochem. 2002 Jun;81(6):1285-97
references.pmid: 12068076
references.citation: Prog Neurobiol. 1997 Feb;51(2):195-222
references.pmid: 9247964
references.citation: Mol Psychiatry. 2007 Nov;12(11):988-1000
references.pmid: 17457312
references.citation: Psychopharmacology (Berl). 2000 Nov;152(4):383-9
references.pmid: 11140330
references.citation: Mol Psychiatry. 2007 Apr;12(4):408-17
references.pmid: 17389906
references.citation: Eur Heart J. 2002 Jun;23(11):831-4
references.pmid: 12042000
references.citation: Brain Res. 1997 Feb 7;747(2):348-51
references.pmid: 9046014
references.citation: Curr Pharm Des. 2005;11(8):999-1016
references.pmid: 15777250
references.citation: J Psychopharmacol. 2000;14(3):214-21
references.pmid: 11106299
references.citation: J Neurochem. 2003 Aug;86(3):774-83
references.pmid: 12859689
references.citation: Psychopharmacology (Berl). 1996 Jul;126(1):91-4
references.pmid: 8853222
references.citation: Mol Psychiatry. 2009 May;14(5):511-22
references.pmid: 18195714
references.citation: Annu Rev Neurosci. 1986;9:357-81
references.pmid: 3085570
references.citation: Neuropsychopharmacology. 2002 May;26(5):643-52
references.pmid: 11927189
references.citation: Neurosci Lett. 1995 Apr 14;189(2):73-6
references.pmid: 7609922
references.citation: Neuropsychopharmacology. 2007 Nov;32(11):2384-92
references.pmid: 17327884
references.citation: Brain Behav Immun. 2001 Sep;15(3):199-226
references.pmid: 11566046
references.citation: Arch Neurol. 2000 Nov;57(11):1601-7
references.pmid: 11074792
references.citation: Mol Psychiatry. 2009 Dec;14(12):1095-104
references.pmid: 18458677
references.citation: J Affect Disord. 2000 Jul;59(1):23-30
references.pmid: 10814767
references.citation: Biol Psychiatry. 2007 Dec 1;62(11):1324-33
references.pmid: 17678633
references.citation: Brain Behav Immun. 1995 Dec;9(4):366-77
references.pmid: 8903853
references.citation: Behav Brain Res. 2006 Nov 25;175(1):90-5
references.pmid: 16971003